Thalidomideโdexamethasone as primary the
โ
Michael Wang; Donna M. Weber; Kay Delasalle; Raymond Alexanian
๐
Article
๐
2005
๐
John Wiley and Sons
๐
English
โ 59 KB
๐ 1 views
## Abstract The value of thalidomideโdexamethasone was assessed in 26 consecutive, previously untreated patients with multiple myeloma of high tumor mass. All showed Hgb < 8.5 g/dL, serum calcium > 11.5 mg/dL, or both. The response rate was 73%, frequency of early death < 3 months was 5%, projected